Sinopharm Tech Holdings Limited (8156) has issued a circular announcing its Annual General Meeting (AGM) set for 19 December 2025 at 11:00 a.m. in Central, Hong Kong. Key proposals include granting general mandates to issue up to 20% of the issued shares (excluding treasury shares) and repurchase up to 10% of those shares. The company notes that such repurchases will only proceed when deemed beneficial, while working capital levels will be carefully considered.

The circular also outlines the re-election of retiring directors and the proposed election of additional independent non-executive directors. Retiring Director Dr. Cheng Yanjie will not seek re-election, while the re-election of certain existing directors and the election of two new independent non-executive directors will be put forth for shareholder approval. The meeting agenda further covers the reappointment of auditors and the presentation of the audited financials for the year ended 30 June 2025.

According to the circular, shareholders who wish to attend or vote by proxy must submit relevant transfer documents to the company’s branch share registrar by 15 December 2025, and proxy forms must be lodged 48 hours before the AGM. All resolutions at the AGM will be voted on by poll, with final results disclosed per GEM rules. The company’s circular is available on both the Stock Exchange’s website and Sinopharm Tech’s official website.